Huntsworth (LON:HNT) had its target price lifted by equities research analysts at Peel Hunt from GBX 80 ($1.08) to GBX 95 ($1.28) in a research note issued on Thursday. The brokerage currently has a “buy” rating on the stock. Peel Hunt’s price target points to a potential upside of 16.21% from the company’s previous close.
Shares of Huntsworth (LON HNT) traded down GBX 1.25 ($0.02) during mid-day trading on Thursday, hitting GBX 81.75 ($1.10). 1,801,267 shares of the company were exchanged, compared to its average volume of 252,798. Huntsworth has a 12-month low of GBX 36 ($0.48) and a 12-month high of GBX 84.50 ($1.14).
In related news, insider Neil Jones acquired 25,000 shares of the firm’s stock in a transaction on Tuesday, September 26th. The stock was bought at an average price of GBX 76 ($1.02) per share, for a total transaction of £19,000 ($25,572.01).
COPYRIGHT VIOLATION WARNING: This story was published by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/12/16/peel-hunt-raises-huntsworth-hnt-price-target-to-gbx-95.html.
Huntsworth plc is a United Kingdom-based public relations and integrated healthcare communications company. The Company operates through segments, including Citigate, Grayling, Huntsworth Health and Red. Citigate offers communications services, including global financial, investor relations, corporate, consumer and public policy communications consultancy with an integrated network across the United Kingdom, Europe, the United States and Asia.
Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.